Rg6234, A Novel Gprc5D T-Cell Engaging Bispecific Antibody, Induces Rapid Responses In Patients With Relapsed/Refractory Multiple Myeloma: Preliminary Results From A First-In-Human Trial
RG6234
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Rg6234, A Novel Gprc5D T-Cell Engaging Bispecific Antibody, Induces Rapid Responses In Patients With Relapsed/Refractory Multiple Myeloma: Preliminary Results From A First-In-Human Trial ### Output: RG6234